Q32 Bio Inc. (QTTB)
NASDAQ: QTTB · Real-Time Price · USD
26.92
-0.37 (-1.34%)
Nov 21, 2024, 1:41 PM EST - Market open
Q32 Bio Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Q32 Bio stock have an average target of 72.33, with a low estimate of 45 and a high estimate of 100. The average target predicts an increase of 168.73% from the current stock price of 26.92.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Q32 Bio stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 2 | 2 |
Buy | 3 | 3 | 3 | 4 | 4 | 4 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 4 | 5 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Raymond James | Raymond James | Strong Buy Initiates $90 | Strong Buy | Initiates | $90 | +234.39% | Oct 24, 2024 |
Wells Fargo | Wells Fargo | Buy Initiates $95 | Buy | Initiates | $95 | +252.96% | Sep 11, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $100 | Strong Buy | Initiates | $100 | +271.54% | Jun 17, 2024 |
Leerink Partners | Leerink Partners | Buy Initiates $54 | Buy | Initiates | $54 | +100.63% | May 21, 2024 |
Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +85.77% | Apr 11, 2024 |
Financial Forecast
Revenue This Year
n/a
from -6.65M
Revenue Next Year
n/a
EPS This Year
-5.54
from -7.41
EPS Next Year
-5.47
from -5.54
Revenue Forecast
Revenue | 2024 | 2025 | 2026 |
---|---|---|---|
High | n/a | n/a | n/a |
Avg | n/a | n/a | n/a |
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 |
---|---|---|---|
High | -5.12 | -4.55 | -2.81 |
Avg | -5.54 | -5.47 | -5.72 |
Low | -5.56 | -6.47 | -6.86 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.